PUBLISHER: IMARC | PRODUCT CODE: 1541469
PUBLISHER: IMARC | PRODUCT CODE: 1541469
The global anesthesia endotracheal tubes market size reached US$ 182.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 282.0 Million by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032.
Anesthesia endotracheal tubes (ETTs) are used for intubation and manufactured using a polyvinylchloride (PVC) tube, which is inserted into the trachea and allows direct delivery of oxygen (O2) and removal of carbon dioxide (CO2) from the lungs. They aid in maintaining the airway passage of the lungsand allowing mechanical ventilation. They are also utilizedfor protecting the lungs from contamination of gastric contents and nasopharyngeal matter and during intermittent positive pressure ventilation (IPPV), resuscitation, Diptheria, epiglottis, and direct suctioning of the trachea in meconium aspiration. They enable healthcare professionals to sedate the patient and performing the surgical procedure. As a result, ETTsare widely used in surgery centers, trauma centers, and intensive care units (ICUs).
The increasing prevalence of chronic disorders and viral infections among the masses, especially the geriatric population, which is more susceptible to thesemedical ailments, represents one of the major factors positively influencing the demand for anesthesia ETTs worldwide. In addition, the rising number of fatal road accidents and the growing number of trauma cases are driving the market. Apart from this, key players are introducing anesthesia ETTs with flexible tips that offer enhanced comfort and convenience to the users and assist in navigating through fragile airways with minimal discomfort. Furthermore, the escalating number of smokers and alcohol consumers is contributing to the market growth. Moreover, increasing incidences of airborne diseases on account of the rising air pollution arecreating a positive outlook in the market. Besides this, the expanding investments in improving healthcare infrastructure and medical services are projected to offer lucrative growth opportunities to industry investors.
IMARC Group provides an analysis of the key trends in each sub-segment of the global anesthesia endotracheal tubes market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on, intubation type, product type, and end user.
Nasotracheal
Orotracheal
Hybrid
Nasotracheal intubation dominates the market as it is easier to secure, moves less, minimizes the risk of trauma to lips, tongue, and larynx, and provides comfort to patients.
Regular Tubes
Reinforced/Armored Tubes
Coated Tubes
Others
Coated tubes currently dominate the market.
Hospitals
Ambulatory Surgery Centers
Others
Anesthesia endotracheal tubes are extensively used in hospitals as it is an emergency procedure performed on people to maintain an open airway and help prevent suffocation.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America holds the majority of the global anesthesia endotracheal tubes market share due to the increasing prevalence of severe chronic ailments among the masses of the region.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Becton, Dickinson and Company, Convatec Limited, Fuji Systems Corp., General Electric (GE) Company, Intersurgical Ltd., Medtronic Private Limited, Neurovision Medical Products, SEWOON MEDICAL Co., Ltd., Smiths Group PLC, and Teleflex Incorporated.